Uncharged mono- and bisoximes: In search of a zwitterion to countermeasure organophosphorus intoxication.
Chem Biol Interact
; 394: 110941, 2024 May 01.
Article
en En
| MEDLINE
| ID: mdl-38493910
ABSTRACT
The current study imposes a new class of organophosphorus (OP)-inhibited cholinesterase reactivators by conceptualizing a family of asymmetric bisoximes with various reactivating scaffolds. Several novel nucleophilic warheads were investigated, putting forward 29 novel reactivating options, by evaluating their nucleophilicity and ability to directly decompose OP compounds. Adopting the so-called zwitterionic strategy, 17 mono-oxime and nine bisoxime reactivators were discovered with major emphasis on the bifunctional-moiety approach. Compounds were compared with clinically used standards and other known experimentally highlighted reactivators. Our results clearly favor the concept of asymmetric bisoximes as leading reactivators in terms of efficacy and versatility. These top-ranked compounds were characterized in detail by reactivation kinetics parameters and evaluated for potential CNS availability. The highlighted molecules 55, 57, and 58 with various reactivating warheads, surpassed the reactivating potency of pralidoxime and several notable uncharged reactivators. The versatility of lead drug candidate 55 was also inspected on OP-inhibited butyrylcholinesterase, revealing a much higher rate compared to existing clinical antidotes.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Oximas
/
Butirilcolinesterasa
/
Reactivadores de la Colinesterasa
/
Intoxicación por Organofosfatos
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Chem Biol Interact
Año:
2024
Tipo del documento:
Article